BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8646821)

  • 1. Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender?
    Ammon E; Schäfer C; Hofmann U; Klotz U
    Clin Pharmacol Ther; 1996 May; 59(5):503-13. PubMed ID: 8646821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in pharmacokinetics of alcohol.
    Baraona E; Abittan CS; Dohmen K; Moretti M; Pozzato G; Chayes ZW; Schaefer C; Lieber CS
    Alcohol Clin Exp Res; 2001 Apr; 25(4):502-7. PubMed ID: 11329488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.
    Levitt MD; Levitt DG
    J Pharmacol Exp Ther; 1994 Apr; 269(1):297-304. PubMed ID: 8169837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism.
    Frezza M; di Padova C; Pozzato G; Terpin M; Baraona E; Lieber CS
    N Engl J Med; 1990 Jan; 322(2):95-9. PubMed ID: 2248624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic ethanol administration on disposition of ethanol and its metabolites in rat.
    Kozawa S; Yukawa N; Liu J; Shimamoto A; Kakizaki E; Fujimiya T
    Alcohol; 2007 Mar; 41(2):87-93. PubMed ID: 17517325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
    Kharasch ED; Hoffer C; Walker A; Sheffels P
    Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a two-compartment model to assess the pharmacokinetics of human ethanol metabolism.
    Levitt MD; Levitt DG
    Alcohol Clin Exp Res; 1998 Nov; 22(8):1680-8. PubMed ID: 9835281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood alcohol concentrations after oral alcohol administration--effect of age and sex].
    Gärtner U; Schmier M; Bogusz M; Seitz HK
    Z Gastroenterol; 1996 Oct; 34(10):675-9. PubMed ID: 9012221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First pass metabolism of ethanol.
    Lieber CS; Gentry RT; Baraona E
    Alcohol Alcohol Suppl; 1994; 2():163-9. PubMed ID: 8974331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of gastric oxidation to ethanol first-pass metabolism in baboons.
    Baraona E; Abittan CS; Lieber CS
    Alcohol Clin Exp Res; 2000 Jul; 24(7):946-51. PubMed ID: 10923995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in the pharmacokinetics of ethanol in saliva and blood after oral ingestion.
    Gubała W; Zuba D
    Pol J Pharmacol; 2003; 55(4):639-44. PubMed ID: 14581724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect.
    Fujimiya T; Fukui Y; Komura S
    Nihon Hoigaku Zasshi; 1995 Apr; 49(2):92-103. PubMed ID: 7783393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethanol elimination rate (beta60, beta-slope) in different age groups after intake of a moderate or high dose of alcohol].
    Barinskaia TO; Smirnov AV; Salomatin EM; Shaev AI
    Sud Med Ekspert; 2009; 52(5):23-7. PubMed ID: 20058846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework.
    Jones AW
    Forensic Sci Int; 2010 Jul; 200(1-3):1-20. PubMed ID: 20304569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of oral azithromycin in humans.
    Luke DR; Foulds G
    Clin Pharmacol Ther; 1997 Jun; 61(6):641-8. PubMed ID: 9209246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.